Latest stories on XENE
Xenon Pharmaceuticals: Epilepsy Got It To $59; Depression Has To Take It From Here
Seeking Alpha73 · bullishproduct/pr
Xenon (XENE) Heads To Europe With Data That Could Reshape Epilepsy Care
Yahoo Finance67 · bullishproduct/pr
Oklo vs. X-Energy: Which One Actually Produces Nuclear Power First?
The Motley Fool54 · neutralgeneral
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Xenon to Spotlight Azetukalner Phase 3 and Mechanistic Data at EEC 2026
TipRanks63 · neutralproduct/pr
Xenon Pharmaceuticals (XENE) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Xenon Pharmaceuticals: Strong Buy On Azetukalner NDA And MDD Expansion Opportunity
Seeking Alpha73 · bullishanalyst
Xenon Pharmaceuticals Q2 Earnings Call Highlights
Yahoo Top56 · neutralearnings
Xenon Pharmaceuticals price target lowered to $81 from $82 at RBC Capital
The Fly48 · neutralanalyst
Xenon anticipates AZK NDA submission later this quarter, while funding operations into 2029
Seeking Alpha63 · neutralproduct/pr
Xenon Pharmaceuticals Inc. (XENE) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Xenon advances azetukalner toward planned U.S. NDA filing
TipRanks63 · neutralproduct/pr
Xenon Pharmaceuticals Reports Q2 Eps 1 11 Consensus 1 16
The Fly34 · bearishearnings
Xenon Pharma Q2 2026 Earnings Preview
Seeking Alpha42 · neutralearnings
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
X-Energy joins $60M project for AI-accelerated advanced nuclear deployment
Seeking Alpha63 · neutralproduct/pr
Xenon Pharmaceuticals: Azetukalner Has Shifted From Binary Science To Commercial Execution
Seeking Alpha67 · bullishproduct/pr
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | XENE Stock News
StockTitan50 · neutralgeneral
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | XENE Stock News
StockTitan50 · neutralgeneral
JPMorgan Raises its Price Target on Xenon Pharmaceuticals (XENE)
Yahoo Top61 · neutralanalyst
Xenon Pharmaceuticals Signals Strong Momentum In Earnings
TipRanks67 · bullishearnings
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing
Yahoo Top63 · neutralproduct/pr